Study: Cannabinoids May Alleviate Dystonia and Other Huntington’s Disease Symptoms

Those with Hungtington’s disease may be able to treat some of their symptoms, including dystonia, with cannabinoids, according to a new study.

“Treatment options for dystonia are limited”, states the study’s abstract. “Cannabinoids have been described as a potential treatment for patients with dystonia of a different origin. Here, we present early onset HD [Huntington’s disease] patients with a marked improvement of motor symptoms mainly due to alleviation of dystonia due to treatment with cannabinoids.” In addition, “we review the current literature concerning the use of cannabinoids in HD. Dystonia is described by the Mayo Clinic as “Involuntary muscle contractions that cause repetitive or twisting movements.”

Read moreStudy: Cannabinoids May Alleviate Dystonia and Other Huntington’s Disease Symptoms

Tennessee House Committee Passes Medical Cannabis Legalization Bill

A proposalmedicanna to legalize the use of cannabis-based medicines for those with a recommendation from a physician has been approved with a unanimous vote by Tennessee’s House Health Subcommittee. The full committee is expected to begin discussing the bill next week.

If approved into law, the proposal – sponsored by Representative Ryan Williams (R-Cookeville) – would allow those with stage II, III or IV terminal cancer, Parkinson’s disease, multiple sclerosis, Huntington’s disease and certain forms of epilepsy to possess and use cannabis pills or patches, if they receive a recommendation from a physician and register with the Tennessee Department of Health. Unfortunately dried cannabis flower will remain illegal even for medical use.

Read moreTennessee House Committee Passes Medical Cannabis Legalization Bill

Cannabis May Improve Motor Symptoms, Stimulate Neuroprotective Processes In Those With Huntington’s Disease

A study published this month in the journal Neuropharmacology, and published online by the U.S. National Institute of Health, has found that prolongednhlegalization administration of a compound meant to mimic the effects of cannabis can improve motor symptoms and stimulate neuroprotective processes in those with Huntington’s disease.

“Huntington’s disease (HD) is a devastating neurodegenerative disease characterized by a progressive decline in motor abilities, as well as in cognitive and social behaviors”, claims the study. “Most of these behavioral deficits are recapitulated in the R6/1 transgenic mouse, which can therefore be used as an experimental model to identify the neurobiological substrates of HD pathology and to design novel therapeutic approaches.”

Read moreCannabis May Improve Motor Symptoms, Stimulate Neuroprotective Processes In Those With Huntington’s Disease

Cannabis May Treat Neurodegeneration According to New Study

A new study published in the British Journal of Pharmacology has found that cannabis may treat neurodegenerative diseases such as Alzheimer’s disease.braincannabis

“In an increasingly ageing population, the incidence of neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease and Huntington’s disease are rising”, according to the study. “While the aetiologies of these disorders are different, a number of common mechanisms that underlie their neurodegenerative components have been elucidated; namely neuroinflammation, excitotoxicity, mitochondrial dysfunction and reduced trophic support. Current therapies focus on treatment of the symptoms and attempt to delay the progression of these diseases but there is currently no cure.” It continues; “Modulation of the endogenous cannabinoid system is emerging as a potentially viable option in the treatment of neurodegeneration. Endocannabinoid signalling has been found to be altered in many neurodegenerative disorders.”

Read moreCannabis May Treat Neurodegeneration According to New Study

Two New Qualifying Conditions Added to New Mexico’s Medical Cannabis Program

Those with Parkinson’s disease and Huntington’s disease who receive a recommendation from their physician will be authorized to possess medical cannabis legally under new rule changes nmapproved by Governor Susana Martinez.

“Friday’s announcement demonstrates the response from the Martinez administration we have been seeking for a long time,” said Emily Kaltenbach, New Mexico Director of the Drug Policy Alliance, which has been trying to get these, and other conditions added to the program for several years now.

Read moreTwo New Qualifying Conditions Added to New Mexico’s Medical Cannabis Program